Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
78.88
-3.63 (-4.40%)
Jun 16, 2026, 4:00 PM EDT - Market closed

Dianthus Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Dianthus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $127.67. The average 1-year stock price forecast is 61.85% higher than the current stock price, while the lowest is $98 (+24.24%) and the highest is $200 (+153.55%).

Price Target: $127.67 (+61.85%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$98$127.67$125$200
Change+24.24%+61.85%+58.47%+153.55%

Analyst Ratings

The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy131313151615
Buy111000
Hold000000
Sell000000
Strong Sell000000
Total141414151615

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 11, 2026
Wedbush
Wedbush
Buy
Maintains
$103$105
BuyMaintains$103$105+33.11%Jun 11, 2026
Jefferies
Jefferies
Buy
Reiterates
$110$132
BuyReiterates$110$132+67.34%Jun 10, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 10, 2026
LifeSci Capital
LifeSci Capital
Buy
Reiterates
$65$125
BuyReiterates$65$125+58.47%Jun 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.21M
from 2.04M
Decreased by -40.59%
Revenue Next Year
1.59M
from 1.21M
Increased by 31.06%
EPS This Year
-3.93
from -4.20
EPS Next Year
-4.65
from -3.93
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.48M6.42M2.83M6.24M2.04M1.21M
Revenue Growth
-334.76%-55.96%120.63%-67.35%-40.59%
Gross Profit
1.48M6.42M2.83M6.24M2.04M1.21M
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Income
-13.09M-29.71M-48.17M-101.86M-177.93M-223.84M
Net Income
-13.11M-28.48M-43.56M-84.97M-162.34M-198.73M
EPS
-----4.20-3.93
Free Cash Flow
--19.31M-22.81M-43.48M-75.45M-168.00M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.5M
Avg1.2M
Lown/a

Revenue Growth

Revenue Growth202620272028
High
70.1%
Avg
-40.6%
Low
-100.0%

EPS Forecast

EPS202620272028
High-3.44
Avg-3.93
Low-5.06

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-